>北美药瓶市场，按材质（玻璃、塑料和其他）、颈部类型（螺旋颈、压接颈、双室、翻盖和其他）、瓶盖尺寸（13-425 毫米、15-425 毫米、18-400 毫米、22-350 毫米、24-400 毫米、8-425 毫米、9 毫米和其他）、分销渠道（直销、药店/药房、电子商务和其他）、容量（1 毫升、2 毫升、3 毫升、4 毫升、8 毫升、10 毫升、20 毫升、30 毫升、50 毫升和其他）、药物类型（注射剂和非注射剂）、应用（口服、鼻腔、注射剂和其他）、最终用户（制药公司、生物制药公司、合同开发和制造公司、复合药房和其他）、市场（肠胃外、胃肠、耳鼻喉和其他）、国家/地区划分（美国、加拿大和墨西哥）行业趋势及 2028 年预测
市场分析和洞察：北美药用瓶市场
预计医药瓶市场将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析称，在 2021 年至 2028 年的预测期内，该市场的复合年增长率为 6.9%，预计到 2028 年将达到 90.0739 亿美元。
药瓶是一种用于储存药物的小型塑料或玻璃或塑料容器，主要用于储存液体，有时也用于储存胶囊形式的液体。药瓶存在于制药公司、生物制药公司、复合药房等各种领域和其他几个地方。药瓶由塑料、玻璃和其他各种材料制成。药瓶有助于延长产品的保质期和耐用性。
多家制造商致力于生产高质量的玻璃和塑料包装产品，这些产品有助于延长药品的保质期。制药行业的多层设计包装产品即使在受力冲击的情况下也能提供额外的完整性保证。对于有毒或高效药物溶液的包装，制药行业对结合抗裂性和完整性性能的包装产品的需求正在增加。
本药用小瓶市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息，分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和市场情景，请联系我们获取分析师简报，我们的团队将帮助您创建收入影响解决方案，以实现您的预期目标。
北美药用瓶市场范围和市场规模
北美药瓶市场根据材料、颈部类型、瓶盖尺寸、分销渠道、容量、药物类型、应用、最终用户和市场进行细分。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。
- 根据材料，药瓶市场分为塑料、玻璃和其他材料。2021 年，玻璃因其无泄漏特性而占据主导地位，推动了药瓶市场的发展。
- 根据瓶颈类型，药瓶市场分为压接瓶颈、双腔瓶颈、螺旋瓶颈、翻盖瓶颈和其他瓶颈。2021 年，螺旋瓶颈市场占据主导地位，因为其在胃肠道领域的应用日益广泛。
- 根据瓶盖尺寸，市场细分为 13-425 MM、15-425 MM、18-400 MM、22-350 MM、24-400 MM、8-425 MM、9MM 等。2021 年，9MM 占主导地位，因为根据需求，加工规模较大。
- 根据分销渠道，市场分为直销、药店/药房、电子商务和其他。2021 年，直销占主导地位，因为与客户建立了庞大的关系，从而推动了药瓶市场的需求。
- 根据容量，市场分为 1 ML、2 ML、3 ML、4 ML、8 ML、10 ML、20 ML、30 ML、50 ML 等。2021 年，1 ML 因其高效率而占据主导地位，从而推动了药瓶市场的需求。
- 根据药物类型，市场分为注射剂和非注射剂。2021 年，注射剂占主导地位，因为它具有控制剂量消耗量的特性，可最大限度地提高其应用范围。
- 根据应用，市场分为鼻腔、口服和其他。2021 年，口服占据主导地位，因为生物制药公司的消费量巨大。
- 根据最终用户，市场分为制药公司、生物制药公司、合同开发和制造公司、复合药房和其他。2021 年，制药公司占据主导地位，因为用于治疗各种疾病的药物不断增加，这是推动药瓶市场需求的原因。
- 根据市场情况，药瓶市场分为肠外、胃肠道、耳鼻喉等。2021 年，肠外市场占据主导地位，因为它具有增强药物依从性的特点。
药瓶市场国家层面分析
对北美药瓶市场进行了分析，并提供了按材料、颈部类型、瓶盖尺寸、分销渠道、容量、药物类型、应用、最终用户和市场划分的市场规模信息。
医药瓶市场报告涵盖的国家包括北美的美国、加拿大和墨西哥。
由于该地区制药行业对包装的需求不断增长，北美药瓶市场占据主导地位。美国在药瓶市场占据主导地位，因为该国药瓶产品生产和消费量很高。此外，产品制造的高度创新和发展也是该国增长的主要因素之一。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在提供国家数据的预测分析时，还考虑了品牌的存在和可用性以及由于来自本地和国内品牌的激烈或稀少的竞争而面临的挑战、销售渠道的影响。
药瓶行业的增长
北美药瓶市场还为您提供每个国家/地区药瓶市场不同类型产品安装基数增长的详细市场分析、使用生命线曲线的技术影响以及婴儿配方奶粉监管情景的变化及其对药瓶市场的影响。数据涵盖 2011 年至 2019 年的历史时期。
竞争格局和药瓶市场份额分析
北美药用小瓶市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、公司优势和劣势、产品发布、临床试验渠道、品牌分析、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对北美药用小瓶市场的关注有关。
报告中涉及的主要参与者包括 Gerresheimer AG、SCHOTT AG、Berry Global Inc.、West Pharmaceutical Services Inc、Origin Pharma Packaging、SGD Pharma、Pacific Vial Manufacturing Inc.、Bormioli Pharma Spa、TOYOBO CO., LTD.、NIPRO、Piramal Glass Private Limited、Corning Incorporated、DWK Life Sciences Ltd、APG 和 Stevanato Group，以及其他国内外参与者。DBMR 分析师了解竞争优势并为每个竞争对手分别提供竞争分析。
- 2020 年 5 月，Piramal Glass Private Limited 公司决定将玻璃包装产品转型为数字玻璃制造商，从而在业务上取得发展。这一发展有助于公司增加收入。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA PHARMACEUTICAL VIALS MARKET
1.4 LIMITATION
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 DRUG TYPE LIFE LINE CURVE
2.7 MULTIVARIATE MODELLING
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 DBMR MARKET CHALLENGE MATRIX
2.12 VENDOR SHARE ANALYSIS
2.13 IMPORT-EXPORT DATA
2.14 SECONDARY SOURCES
2.15 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PREMIUM INSIGHTS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 GROWING DEMAND OF PACKAGING IN PHARMACEUTICAL INDUSTRY
5.1.2 GROWING DEMAND FOR DRUG DELIVERY DEVICES AND BLISTER PACKAGING
5.1.3 GROWTH OF PREFILLED SYRINGES
5.1.4 GROWING HEALTH AWARENESS AND ADOPTION OF NEW TECHNIQUES FOR STORAGE OF LIQUID MEDICINE
5.2 RESTRAINTS
5.2.1 CHEMICALS RELEASE OF THE INTERNAL SURFACE OF GLASS TUBING CONTAINERS
5.2.2 INCREASING COST OF OVERALL PACKAGING
5.3 OPPORTUNITIES
5.3.1 IMPLEMENTING READY-TO USE GLASS VIALS FOR FLEXIBLE ASEPTIC FILLING
5.3.2 INCREASING DEMAND OF PACKAGING FOR COVID-19 VACCINE
5.4 CHALLENGES
5.4.1 RECYCLING OF WASTE PRODUCE BY PHARMACEUTICAL PACKAGING
5.4.2 INCREASING GOVERNMENT REGULATIONS TOWARDS PHARMACEUTICAL SECTOR
6 COVID-19 IMPACT ON THE PHARMACEUTICAL VIALS MARKET IN CHEMICAL AND MATERIALS INDUSTRY
6.1 ANALYSIS ON IMPACT OF COVID-19 ON THE NORTH AMERICA PHARMACEUTICAL VIALS MARKET
6.2 AFTERMATH OF COVID-19 AND GOVERNMENT INITIATIVE TO BOOST THE NORTH AMERICA PHARMACEUTICAL VIALS MARKET
6.3 STRATEGIC DECISIONS FOR MANUFACTURERS AFTER COVID-19 TO GAIN COMPETITIVE MARKET SHARE
6.4 PRICE IMPACT
6.5 IMPACT ON DEMAND
6.6 IMPACT ON SUPPLY CHAIN
6.7 CONCLUSION
7 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY MATERIAL
7.1 OVERVIEW
7.2 GLASS
7.2.1 GLASS BY COLOR
7.2.1.1 Amber
7.2.1.2 Clear
7.2.1.3 Others
7.2.2 GLASS BY TYPE
7.2.2.1 TYPE I (Borosilicate Glass)
7.2.2.2 TYPE II (Treated Soda-Lime Glass)
7.2.2.3 TYPE III (Regular Soda Lime Glass)
7.2.2.4 TYPE IV (Type Np Glass/General-Purpose Soda Lime Glass)
7.2.3 GLASS BY PRODUCT
7.2.3.1 Serum / Specialty Glass Vials
7.2.3.2 Screw Thread Glass Vials
7.2.3.3 Sterile Glass Vials
7.2.3.4 Sample Glass Vials
7.2.3.5 Autosampler Vials
7.2.3.6 Chromatography Vials
7.2.3.7 Epa Voa Vials
7.2.3.8 Others
7.3 PLASTIC
7.3.1 PLASTIC BY COLOR
7.3.1.1 Translucent
7.3.1.2 Opaque
7.3.1.3 Others
7.3.2 PLASTIC BY TYPE
7.3.2.1 High-density polyethylene (HDPE)
7.3.2.2 Polystyrene
7.3.2.3 Polypropylene
7.3.2.4 Polyvinyl Chloride (PVC)
7.3.2.5 Polycarbonate
7.3.2.6 Polyester
7.3.2.7 Others
7.4 OTHERS
8 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY NECK TYPE
8.1 OVERVIEW
8.2 SCREW NECK
8.3 CRIMP NECK
8.4 DOUBLE CHAMBER
8.5 FLIP CAP
8.6 OTHERS
9 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY CAP SIZE
9.1 OVERVIEW
9.2 9MM
9.3 8-425 MM
9.4 13-425 MM
9.5 15-425 MM
9.6 18-400 MM
9.7 22-350 MM
9.8 24-400 MM
9.9 OTHERS
10 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 DIRECT SALES
10.3 MEDICAL STORES/PHARMACIES
10.4 E-COMMERCE
10.5 OTHERS
11 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY CAPACITY
11.1 OVERVIEW
11.2 1 ML
11.3 2 ML
11.4 3 ML
11.5 4 ML
11.6 8 ML
11.7 10 ML
11.8 20 ML
11.9 30 ML
11.1 50 ML
11.11 OTHERS
12 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY DRUG TYPE
12.1 OVERVIEW
12.2 INJECTABLE
12.2.1 INJECTABLE TYPE
12.2.1.1 Lyophilized
12.2.1.2 Liquid
12.3 NON-INJECTABLE
12.3.1 NON-INJECTABLE TYPE
12.3.1.1 Diagnostic
12.3.1.2 Solid
13 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY APPLICATION
13.1 OVERVIEW
13.2 ORAL
13.3 NASAL
13.4 OTHERS
14 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY END-USER
14.1 OVERVIEW
14.2 PHARMACEUTICAL COMPANIES
14.3 BIOPHARMACEUTICAL COMPANIES
14.4 CONTRACT DEVELOPMENT AND MANUFACTURING COMPANIES
14.5 COMPOUND PHARMACY
14.6 OTHERS
15 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY MARKET
15.1 OVERVIEW
15.2 PARENTERAL
15.3 GASTRO
15.4 ENT
15.5 OTHERS
16 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY GEOGRAPHY
16.1 OVERVIEW
16.2 NORTH AMERICA
16.2.1 U.S.
16.2.2 CANADA
16.2.3 MEXICO
17 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: COMPANY LANDSCAPE
17.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
17.2 MERGERS & ACQUISITIONS
17.3 EXPANSIONS
17.4 NEW PRODUCT DEVELOPMENT
18 SWOT ANALYSIS
19 COMPANY PROFILES
19.1 BERRY NORTH AMERICA INC.
19.1.1 COMPANY SNAPSHOT
19.1.2 REVENUE ANALYSIS
19.1.3 COMPANY SHARE ANALYSIS
19.1.4 PRODUCT PORTFOLIO
19.1.5 RECENT UPDATE
19.2 WEST PHARMACEUTICAL SERVICES, INC.
19.2.1 COMPANY SNAPSHOT
19.2.2 REVENUE ANALYSIS
19.2.3 COMPANY SHARE ANALYSIS
19.2.4 PRODUCT PORTFOLIO
19.2.5 RECENT UPDATE
19.3 PIRAMAL GLASS PRIVATE LIMITED (A SUBSIDIARY OF PIRAMAL ENTERPRISES LTD.)
19.3.1 COMPANY SNAPSHOT
19.3.2 REVENUE ANALYSIS
19.3.3 COMPANY SHARE ANALYSIS
19.3.4 PRODUCT PORTFOLIO
19.3.5 RECENT UPDATE
19.4 TOYOBO CO., LTD.
19.4.1 COMPANY SNAPSHOT
19.4.2 REVENUE ANALYSIS
19.4.3 COMPANY SHARE ANALYSIS
19.4.4 PRODUCT PORTFOLIO
19.4.5 RECENT UPDATE
19.5 CORNING INCORPORATED
19.5.1 COMPANY SNAPSHOT
19.5.2 REVENUE ANALYSIS
19.5.3 COMPANY SHARE ANALYSIS
19.5.4 PRODUCT PORTFOLIO
19.5.5 RECENT UPDATES
19.6 GERRESHEIMER AG
19.6.1 COMPANY SNAPSHOT
19.6.2 REVENUE ANALYSIS
19.6.3 PRODUCT PORTFOLIO
19.6.4 RECENT UPDATE
19.7 NIPRO
19.7.1 COMPANY SNAPSHOT
19.7.2 REVENUE ANALYSIS
19.7.3 PRODUCT PORTFOLIO
19.7.4 RECENT UPDATE
19.8 SCHOTT AG
19.8.1 COMPANY SNAPSHOT
19.8.2 PRODUCT PORTFOLIO
19.8.3 RECENT UPDATE
19.9 APG
19.9.1 COMPANY SNAPSHOT
19.9.2 PRODUCT PORTFOLIO
19.9.3 RECENT UPDATE
19.1 BORMIOLI PHARMA S.P.A.
19.10.1 COMPANY SNAPSHOT
19.10.2 PRODUCT PORTFOLIO
19.10.3 RECENT UPDATE
19.11 DWK LIFE SCIENCES LTD.
19.11.1 COMPANY SNAPSHOT
19.11.2 PRODUCT PORTFOLIO
19.11.3 RECENT UPDATE
19.12 ORIGIN PHARMA PACKAGING
19.12.1 COMPANY SNAPSHOT
19.12.2 PRODUCT PORTFOLIO
19.12.3 RECENT UPDATE
19.13 PACIFIC VIAL
19.13.1 COMPANY SNAPSHOT
19.13.2 PRODUCT PORTFOLIO
19.13.3 RECENT UPDATE
19.14 SGD PHARMA (A SUBSIDIARY OF SAINT-GOBAIN)
19.14.1 COMPANY SNAPSHOT
19.14.2 REVENUE ANALYSIS
19.14.3 PRODUCT PORTFOLIO
19.14.4 RECENT UPDATE
19.15 STEVANATO GROUP
19.15.1 COMPANY SNAPSHOT
19.15.2 PRODUCT PORTFOLIO
19.15.3 RECENT UPDATE
20 QUESTIONNAIRE
21 RELATED REPORTS
表格列表
LIST OF TABLES
TABLE 1 IMPORT DATA OF PRODUCT: 7010 CARBOYS, BOTTLES, FLASKS, JARS, POTS, PHIALS, AMPOULES AND OTHER CONTAINERS, OF GLASS, OF A.....HS CODE: 7010 (USD THOUSAND)
TABLE 2 EXPORT DATA OF PRODUCT: 7010 CARBOYS, BOTTLES, FLASKS, JARS, POTS, PHIALS, AMPOULES AND OTHER CONTAINERS, OF GLASS, OF A.....HS CODE: 7010 (USD THOUSAND)
TABLE 3 TIME TAKEN FOR GARBAGE TO DECOMPOSE IN THE ENVIRONMENT (2015)
TABLE 4 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY MATERIAL, 2019-2028 (USD MILLION)
TABLE 5 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY TYPE, 2019-2028 (MILLION UNITS)
TABLE 6 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, GLASS BY REGION, 2019-2028 (USD MILLION)
TABLE 7 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, GLASS BY REGION, 2019-2028 (MILLION UNITS)
TABLE 8 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, GLASS BY COLOR, 2019-2028 (USD MILLION)
TABLE 9 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, GLASS BY TYPE, 2019-2028 (USD MILLION)
TABLE 10 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, GLASS BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 11 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, PLASTIC BY REGION, 2019-2028 (USD MILLION)
TABLE 12 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, PLASTIC BY REGION, 2019-2028 (MILLION UNITS)
TABLE 13 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, PLASTIC BY COLOR, 2019-2028 (USD MILLION)
TABLE 14 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, PLASTIC BY TYPE, 2019-2028 (USD MILLION)
TABLE 15 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, OTHERS BY REGION, 2019-2028 (USD MILLION)
TABLE 16 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, OTHERS BY REGION, 2019-2028 (MILLION UNITS)
TABLE 17 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY NECK TYPE, 2019-2028 (USD MILLION)
TABLE 18 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, SCREW NECK BY REGION, 2019-2028 (USD MILLION)
TABLE 19 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, CRIMP NECK BY REGION, 2019-2028 (USD MILLION)
TABLE 20 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, DOUBLE CHAMBER BY REGION, 2019-2028 (USD MILLION)
TABLE 21 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, FLIP CAP BY REGION, 2019-2028 (USD MILLION)
TABLE 22 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, OTHERS BY REGION, 2019-2028 (USD MILLION)
TABLE 23 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY CAP SIZE, 2019-2028 (USD MILLION)
TABLE 24 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 9MM BY REGION, 2019-2028 (USD MILLION)
TABLE 25 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 8-425 MM BY REGION, 2019-2028 (USD MILLION)
TABLE 26 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 13-425 MM BY REGION, 2019-2028 (USD MILLION)
TABLE 27 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 15-425 MM BY REGION, 2019-2028 (USD MILLION)
TABLE 28 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 18-400 MM BY REGION, 2019-2028 (USD MILLION)
TABLE 29 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 22-350 MM BY REGION, 2019-2028 (USD MILLION)
TABLE 30 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 24-400 MM BY REGION, 2019-2028 (USD MILLION)
TABLE 31 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, OTHERS BY REGION, 2019-2028 (USD MILLION)
TABLE 32 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 33 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, DIRECT SALES BY REGION, 2019-2028 (USD MILLION)
TABLE 34 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, MEDICAL STORES/PHARMACIES BY REGION, 2019-2028 (USD MILLION)
TABLE 35 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, E-COMMERCE BY REGION, 2019-2028 (USD MILLION)
TABLE 36 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, OTHERS BY REGION, 2019-2028 (USD MILLION)
TABLE 37 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY CAPACITY, 2019-2028 (USD MILLION)
TABLE 38 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 1 ML BY REGION, 2019-2028 (USD MILLION)
TABLE 39 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 2 ML BY REGION, 2019-2028 (USD MILLION)
TABLE 40 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 3 ML BY REGION, 2019-2028 (USD MILLION)
TABLE 41 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 4 ML BY REGION, 2019-2028 (USD MILLION)
TABLE 42 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 8 ML BY REGION, 2019-2028 (USD MILLION)
TABLE 43 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 10 ML BY REGION, 2019-2028 (USD MILLION)
TABLE 44 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 20 ML BY REGION, 2019-2028 (USD MILLION)
TABLE 45 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 30 ML BY REGION, 2019-2028 (USD MILLION)
TABLE 46 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, 50 ML BY REGION, 2019-2028 (USD MILLION)
TABLE 47 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, OTHERS BY REGION, 2019-2028 (USD MILLION)
TABLE 48 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)
TABLE 49 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, INJECTABLE BY REGION, 2019-2028 (USD MILLION)
TABLE 50 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY INJECTABLE TYPE, 2019-2028 (USD MILLION)
TABLE 51 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, NON-INJECTABLE BY REGION, 2019-2028 (USD MILLION)
TABLE 52 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY NON-INJECTABLE TYPE, 2019-2028 (USD MILLION)
TABLE 53 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 54 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, ORAL BY REGION, 2019-2028 (USD MILLION)
TABLE 55 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, NASAL BY REGION, 2019-2028 (USD MILLION)
TABLE 56 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, OTHERS BY REGION, 2019-2028 (USD MILLION)
TABLE 57 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY END-USER, 2019-2028 (USD MILLION)
TABLE 58 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, PHARMACEUTICAL COMPANIES BY REGION, 2019-2028 (USD MILLION)
TABLE 59 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BIOPHARMACEUTICAL COMPANIES BY REGION, 2019-2028 (USD MILLION)
TABLE 60 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, CONTRACT DEVELOPMENT AND MANUFACTURING COMPANIES BY REGION, 2019-2028 (USD MILLION)
TABLE 61 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, COMPOUND PHARMACY BY REGION, 2019-2028 (USD MILLION)
TABLE 62 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, OTHERS BY REGION, 2019-2028 (USD MILLION)
TABLE 63 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY MARKET, 2019-2028 (USD MILLION)
TABLE 64 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, PARENTERAL BY REGION, 2019-2028 (USD MILLION)
TABLE 65 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, GASTRO BY REGION, 2019-2028 (USD MILLION)
TABLE 66 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, ENT BY REGION, 2019-2028 (USD MILLION)
TABLE 67 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, OTHERS BY REGION, 2019-2028 (USD MILLION)
TABLE 69 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY REGION, 2018-2027 (MILLION UNITS)
TABLE 70 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 71 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY COUNTRY ,2019-2028 (USD MILLION)
TABLE 72 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY COUNTRY ,2019-2028 (MILLION UNITS)
TABLE 73 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY MATERIAL, 2019-2028 (USD MILLION)
TABLE 74 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY MATERIAL, 2019-2028 (MILLION UNITS)
TABLE 75 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, GLASS BY COLOR, 2019-2028 (USD MILLION)
TABLE 76 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, GLASS BY TYPE, 2019-2028 (USD MILLION)
TABLE 77 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, GLASS BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 78 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, PLASTIC BY COLOR, 2019-2028 (USD MILLION)
TABLE 79 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, PLASTIC BY TYPE, 2019-2028 (USD MILLION)
TABLE 80 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY NECK TYPE,2019-2028 (USD MILLION)
TABLE 81 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY CAP SIZE,2019-2028 (USD MILLION)
TABLE 82 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY DISTRIBUTION CHANNEL,2019-2028 (USD MILLION)
TABLE 83 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY CAPACITY,2019-2028 (USD MILLION)
TABLE 84 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY DRUG TYPE,2019-2028 (USD MILLION)
TABLE 85 NORTH AMERICA PHARMACEUTICAL VIALS MARKET IN DRUG TYPE, BY INJECTABLE,2019-2028 (USD MILLION)
TABLE 86 NORTH AMERICA PHARMACEUTICAL VIALS MARKET IN DRUG TYPE, BY NON-INJECTABLE,2019-2028 (USD MILLION)
TABLE 87 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY APPLICATION,2019-2028 (USD MILLION)
TABLE 88 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY END-USER,2019-2028 (USD MILLION)
TABLE 89 NORTH AMERICA PHARMACEUTICAL VIALS MARKET, BY MARKET,2019-2028 (USD MILLION)
TABLE 90 U.S. PHARMACEUTICAL VIALS MARKET, BY MATERIAL, 2019-2028 (USD MILLION)
TABLE 91 U.S. PHARMACEUTICAL VIALS MARKET, BY MATERIAL, 2019-2028 (MILLION UNITS)
TABLE 92 U.S. PHARMACEUTICAL VIALS MARKET, GLASS BY COLOR, 2019-2028 (USD MILLION)
TABLE 93 U.S. PHARMACEUTICAL VIALS MARKET, GLASS BY TYPE, 2019-2028 (USD MILLION)
TABLE 94 U.S. PHARMACEUTICAL VIALS MARKET, GLASS BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 95 U.S. PHARMACEUTICAL VIALS MARKET, PLASTIC BY COLOR, 2019-2028 (USD MILLION)
TABLE 96 U.S. PHARMACEUTICAL VIALS MARKET, PLASTIC BY TYPE, 2019-2028 (USD MILLION)
TABLE 97 U.S. PHARMACEUTICAL VIALS MARKET, BY NECK TYPE,2019-2028 (USD MILLION)
TABLE 98 U.S. PHARMACEUTICAL VIALS MARKET, BY CAP SIZE,2019-2028 (USD MILLION)
TABLE 99 U.S. PHARMACEUTICAL VIALS MARKET, BY DISTRIBUTION CHANNEL,2019-2028 (USD MILLION)
TABLE 100 U.S. PHARMACEUTICAL VIALS MARKET, BY CAPACITY,2019-2028 (USD MILLION)
TABLE 101 U.S. PHARMACEUTICAL VIALS MARKET, BY DRUG TYPE,2019-2028 (USD MILLION)
TABLE 102 U.S. PHARMACEUTICAL VIALS MARKET IN DRUG TYPE, BY INJECTABLE,2019-2028 (USD MILLION)
TABLE 103 U.S. PHARMACEUTICAL VIALS MARKET IN DRUG TYPE, BY NON-INJECTABLE,2019-2028 (USD MILLION)
TABLE 104 U.S. PHARMACEUTICAL VIALS MARKET, BY APPLICATION,2019-2028 (USD MILLION)
TABLE 105 U.S. PHARMACEUTICAL VIALS MARKET, BY END-USER,2019-2028 (USD MILLION)
TABLE 106 U.S. PHARMACEUTICAL VIALS MARKET, BY MARKET,2019-2028 (USD MILLION)
TABLE 107 CANADA PHARMACEUTICAL VIALS MARKET, BY MATERIAL, 2019-2028 (USD MILLION)
TABLE 108 CANADA PHARMACEUTICAL VIALS MARKET, BY MATERIAL, 2019-2028 (MILLION UNITS)
TABLE 109 CANADA PHARMACEUTICAL VIALS MARKET, GLASS BY COLOR, 2019-2028 (USD MILLION)
TABLE 110 CANADA PHARMACEUTICAL VIALS MARKET, GLASS BY TYPE, 2019-2028 (USD MILLION)
TABLE 111 CANADA PHARMACEUTICAL VIALS MARKET, GLASS BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 112 CANADA PHARMACEUTICAL VIALS MARKET, PLASTIC BY COLOR, 2019-2028 (USD MILLION)
TABLE 113 CANADA PHARMACEUTICAL VIALS MARKET, PLASTIC BY TYPE, 2019-2028 (USD MILLION)
TABLE 114 CANADA PHARMACEUTICAL VIALS MARKET, BY NECK TYPE,2019-2028 (USD MILLION)
TABLE 115 CANADA PHARMACEUTICAL VIALS MARKET, BY CAP SIZE,2019-2028 (USD MILLION)
TABLE 116 CANADA PHARMACEUTICAL VIALS MARKET, BY DISTRIBUTION CHANNEL,2019-2028 (USD MILLION)
TABLE 117 CANADA PHARMACEUTICAL VIALS MARKET, BY CAPACITY,2019-2028 (USD MILLION)
TABLE 118 CANADA PHARMACEUTICAL VIALS MARKET, BY DRUG TYPE,2019-2028 (USD MILLION)
TABLE 119 CANADA PHARMACEUTICAL VIALS MARKET IN DRUG TYPE, BY INJECTABLE,2019-2028 (USD MILLION)
TABLE 120 CANADA PHARMACEUTICAL VIALS MARKET IN DRUG TYPE, BY NON-INJECTABLE,2019-2028 (USD MILLION)
TABLE 121 CANADA PHARMACEUTICAL VIALS MARKET, BY APPLICATION,2019-2028 (USD MILLION)
TABLE 122 CANADA PHARMACEUTICAL VIALS MARKET, BY END-USER,2019-2028 (USD MILLION)
TABLE 123 CANADA PHARMACEUTICAL VIALS MARKET, BY MARKET,2019-2028 (USD MILLION)
TABLE 124 MEXICO PHARMACEUTICAL VIALS MARKET, BY MATERIAL, 2019-2028 (USD MILLION)
TABLE 125 MEXICO PHARMACEUTICAL VIALS MARKET, BY MATERIAL, 2019-2028 (MILLION UNITS)
TABLE 126 MEXICO PHARMACEUTICAL VIALS MARKET, GLASS BY COLOR, 2019-2028 (USD MILLION)
TABLE 127 MEXICO PHARMACEUTICAL VIALS MARKET, GLASS BY TYPE, 2019-2028 (USD MILLION)
TABLE 128 MEXICO PHARMACEUTICAL VIALS MARKET, GLASS BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 129 MEXICO PHARMACEUTICAL VIALS MARKET, PLASTIC BY COLOR, 2019-2028 (USD MILLION)
TABLE 130 MEXICO PHARMACEUTICAL VIALS MARKET, PLASTIC BY TYPE, 2019-2028 (USD MILLION)
TABLE 131 MEXICO PHARMACEUTICAL VIALS MARKET, BY NECK TYPE,2019-2028 (USD MILLION)
TABLE 132 MEXICO PHARMACEUTICAL VIALS MARKET, BY CAP SIZE,2019-2028 (USD MILLION)
TABLE 133 MEXICO PHARMACEUTICAL VIALS MARKET, BY DISTRIBUTION CHANNEL,2019-2028 (USD MILLION)
TABLE 134 MEXICO PHARMACEUTICAL VIALS MARKET, BY CAPACITY,2019-2028 (USD MILLION)
TABLE 135 MEXICO PHARMACEUTICAL VIALS MARKET, BY DRUG TYPE,2019-2028 (USD MILLION)
TABLE 136 MEXICO PHARMACEUTICAL VIALS MARKET IN DRUG TYPE, BY INJECTABLE,2019-2028 (USD MILLION)
TABLE 137 MEXICO PHARMACEUTICAL VIALS MARKET IN DRUG TYPE, BY NON-INJECTABLE,2019-2028 (USD MILLION)
TABLE 138 MEXICO PHARMACEUTICAL VIALS MARKET, BY APPLICATION,2019-2028 (USD MILLION)
TABLE 139 MEXICO PHARMACEUTICAL VIALS MARKET, BY END-USER,2019-2028 (USD MILLION)
TABLE 140 MEXICO PHARMACEUTICAL VIALS MARKET, BY MARKET,2019-2028 (USD MILLION)
图片列表
LIST OF FIGURES
FIGURE 1 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: THE DRUG TYPE LIFE LINE CURVE
FIGURE 7 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 10 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: THE MARKET CHALLENGE MATRIX
FIGURE 11 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: SEGMENTATION
FIGURE 12 GROWING DEMAND FOR DRUG DELIVERY DEVICES AND BLISTER PACKAGING IS DRIVING THE NORTH AMERICA PHARMACEUTICAL VIALS MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 GLASS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA PHARMACEUTICAL VIALS MARKET IN 2021 & 2028
FIGURE 14 NORTH AMERICA IS THE FASTEST GROWING MARKET FOR PHARMACEUTICAL VIALS MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA PHARMACEUTICAL VIALS MARKET
FIGURE 16 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY MATERIAL, 2020
FIGURE 17 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY NECK TYPE, 2020
FIGURE 18 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY CAP SIZE, 2020
FIGURE 19 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 20 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY CAPACITY, 2020
FIGURE 21 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY DRUG TYPE, 2020
FIGURE 22 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY APPLICATION, 2020
FIGURE 23 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY END-USER, 2020
FIGURE 24 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY MARKET, 2020
FIGURE 25 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: SNAPSHOT (2019)
FIGURE 26 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY GEOGRAPHY (2019)
FIGURE 27 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY GEOGRAPHY (2020 & 2027)
FIGURE 28 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY GEOGRAPHY (2019 & 2027)
FIGURE 29 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY MATERIAL (2020-2027)
FIGURE 30 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: SNAPSHOT (2020)
FIGURE 31 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY COUNTRY (2020)
FIGURE 32 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY COUNTRY (2021 & 2028)
FIGURE 33 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY COUNTRY (2020 & 2028)
FIGURE 34 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: BY MATERIAL (2021-2028)
FIGURE 35 NORTH AMERICA PHARMACEUTICAL VIALS MARKET: COMPANY SHARE 2020 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
